Shengchun Kong
44 works · 1,199 citations · h-index 15
Top works
- IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
- Abstract CT216: IMpower150 final analysis: Efficacy of atezolizumab (atezo) + bevacizumab (bev) and chemotherapy in first-line (1L) metastatic nonsquamous (nsq) non-small cell lung cancer (NSCLC) across key subgroups
- Non-asymptotic oracle inequalities for the high-dimensional cox regression via lasso
- Changes in Iron Measures over Menopause and Associations with Insulin Resistance
- Conditional Modeling of Longitudinal Data With Terminal Event
- Endogenous Sex Hormone Changes in Postmenopausal Women in the Diabetes Prevention Program
- Racial/Ethnic Differences in Sex Hormone Levels among Postmenopausal Women in the Diabetes Prevention Program
- Semiparametric approach to regression with a covariate subject to a detection limit
- Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study
- Weight loss decreases follicle stimulating hormone in overweight postmenopausal women
- Sex differences in the association of fasting and postchallenge glucose levels with grip strength among older adults: the Rancho Bernardo Study
- Reductions in glucose among postmenopausal women who use and do not use estrogen therapy
- Racial/ethnic differences in hepatic steatosis in a population‐based cohort of post‐menopausal women: the Michigan Study of Women's Health Across the Nation
- Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
- Sex Hormone Binding Globulin and Sex Steroids Among Premenopausal Women in the Diabetes Prevention Program
- Weighted Approach for Estimating Effects in Principal Strata With Missing Data for a Categorical Post-Baseline Variable in Randomized Controlled Trials
- A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
- A semiparametric imputation approach for regression with censored covariate with application to an AMD progression study
- The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program